T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XYZ
Block Inc
XYZ
|
+$2.39B |
| 2 |
Carvana
CVNA
|
+$1.82B |
| 3 |
Microsoft
MSFT
|
+$1.5B |
| 4 |
Walt Disney
DIS
|
+$1.25B |
| 5 |
Spotify
SPOT
|
+$1.05B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$2.65B |
| 2 |
Intuit
INTU
|
+$2.08B |
| 3 |
Match Group
MTCH
|
+$1.87B |
| 4 |
Salesforce
CRM
|
+$1.76B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.61B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.15% |
| 2 | Healthcare | 16.26% |
| 3 | Consumer Discretionary | 15.34% |
| 4 | Communication Services | 13.82% |
| 5 | Financials | 12.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GRMN
1126
Garmin
GRMN
$59.8B
| $36M | ﹤0.01% |
231,512
-3,594
| -2% | -$584K |
|
1127
Ingevity
NGVT
$2.62B
| $35.7M | ﹤0.01% |
500,516
-18,110
| -3% | -$1.43M |
|
1128
Cogent Communications
CCOI
$530M
| $35.5M | ﹤0.01% |
500,790
+446
| +0.1% | +$33.2K |
|
1129
Enbridge
ENB
$112B
| $35.4M | ﹤0.01% |
890,401
-23,656
| -3% | -$933K |
|
1130
Akamai
AKAM
$18B
| $35.2M | ﹤0.01% |
336,575
-133,949
| -28% | -$15.3M |
|
1131
Extra Space Storage
EXR
$31B
| $35.2M | ﹤0.01% |
209,422
-1,895
| -0.9% | -$335K |
|
|
ARCE
1132
DELISTED
Arco Platform Limited Class A Common Shares
ARCE
| $35.1M | ﹤0.01% |
+1,616,900
| New | +$41.9M |
|
1133
SelectQuote
SLQT
$126M
| $35M | ﹤0.01% |
2,703,104
-3,979,923
| -60% | -$59.9M |
|
1134
Lincoln Electric
LECO
$15.6B
| $34.9M | ﹤0.01% |
270,751
-9,092
| -3% | -$1.24M |
|
|
DAWN
1135
DELISTED
Day One Biopharmaceuticals
DAWN
| $34.9M | ﹤0.01% |
1,506,326
+930
| +0.1% | +$22.3K |
|
1136
DTE Energy
DTE
$28.9B
| $34.7M | ﹤0.01% |
310,785
-382,221
| -55% | -$44.8M |
|
|
PFHD
1137
DELISTED
Professional Holding Corp. Class A Common stock
PFHD
| $34.7M | ﹤0.01% |
1,844,810
+3,948
| +0.2% | +$75K |
|
1138
Xylem
XYL
$28.1B
| $34.5M | ﹤0.01% |
278,745
-5,807
| -2% | -$747K |
|
1139
ScottsMiracle-Gro
SMG
$3.62B
| $34.4M | ﹤0.01% |
235,153
-8,266
| -3% | -$1.35M |
|
1140
Stoneridge
SRI
$197M
| $34.4M | ﹤0.01% |
1,686,942
-21,543
| -1% | -$533K |
|
|
CMLTU
1141
DELISTED
CM Life Sciences III Inc. Unit
CMLTU
| $34.3M | ﹤0.01% |
3,292,388
-3,015
| -0.1% | -$31.5K |
|
1142
Abercrombie & Fitch
ANF
$4.84B
| $34.2M | ﹤0.01% |
910,147
-32,311
| -3% | -$1.25M |
|
|
AEPPZ
1143
DELISTED
American Electric Power Company, Inc. Corporate Units
AEPPZ
| $34.2M | ﹤0.01% |
690,356
-770
| -0.1% | -$40.3K |
|
1144
Mid-America Apartment Communities
MAA
$15.4B
| $34.2M | ﹤0.01% |
183,127
-3,726
| -2% | -$699K |
|
1145
Mesa Laboratories
MLAB
$631M
| $34.1M | ﹤0.01% |
112,794
-78,630
| -41% | -$22.3M |
|
|
AMK
1146
DELISTED
AssetMark Financial Holdings, Inc.
AMK
| $34.1M | ﹤0.01% |
1,370,243
+660,747
| +93% | +$17.1M |
|
|
ATC
1147
DELISTED
Atotech Limited
ATC
| $34M | ﹤0.01% |
1,408,180
-4,996,058
| -78% | -$120M |
|
1148
Rapid Micro Biosystems
RPID
$85.3M
| $33.9M | ﹤0.01% |
+1,856,042
| New | +$38.3M |
|
1149
KeyCorp
KEY
$24.6B
| $33.8M | ﹤0.01% |
1,565,449
-30,160
| -2% | -$610K |
|
1150
Dover
DOV
$28B
| $33.8M | ﹤0.01% |
217,520
-3,996
| -2% | -$662K |
|
Similar funds
T. Rowe Price Associates's Q3 2021 Portfolio in Review
As of Q3 2021, T. Rowe Price Associates held 3,048 positions worth $1.06T, down 1.6% from $1.08T the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q3 2021 filing shows 131 new, 1,029 increased, 1,524 reduced and 112 closed positions. Its largest new stake was Warby Parker: 17,643,113 shares worth $936M. The largest sale was Visa, an estimated $2.65B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2021 buy was Warby Parker: 17,643,113 shares worth $936M.
- T. Rowe Price Associates added most to Block Inc in Q3 2021, an estimated $2.39B increase.
- T. Rowe Price Associates's biggest Q3 2021 reduction was Visa, cutting an estimated $2.65B.
- T. Rowe Price Associates fully exited Maxim Integrated Products in Q3 2021, selling an estimated $394M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $1.06T portfolio in Q3 2021.
- T. Rowe Price Associates opened 131 new positions and closed 112 in Q3 2021.
- T. Rowe Price Associates's portfolio value fell 1.6% quarter-over-quarter to $1.06T.
Based on T. Rowe Price Associates's 13F filing for Q3 2021, filed 15 Nov 2021.